Institutional investors purchased a net $316.7 thousand shares of SCMP during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 41.45% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
METLIFE SECURITIES, INC. Bought 60.5 Thousand shares of Sucampo Pharmaceuticals I...
EQIS CAPITAL MANAGEMENT, INC. Bought 19.1 Thousand shares of Sucampo Pharmaceuticals I...